Samjo Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Sell
59,645
-500
-0.8% -$13.3K 0.72% 34
2025
Q4
$1.5M Sell
60,145
-3,500
-5% -$88.3K 0.58% 38
2025
Q3
$1.62M Sell
63,645
-2,000
-3% -$49.4K 0.62% 38
2025
Q2
$1.59M Sell
65,645
-50
-0.1% -$1.17K 0.67% 35
2025
Q1
$1.66M Sell
65,695
-100
-0.2% -$2.62K 0.71% 32
2024
Q4
$1.75M Sell
65,795
-15,130
-19% -$410K 0.66% 32
2024
Q3
$2.34M Buy
80,925
+18,065
+29% +$527K 0.81% 24
2024
Q2
$1.76M Hold
62,860
0.66% 26
2024
Q1
$1.74M Buy
62,860
+900
+1% +$25K 0.61% 25
2023
Q4
$1.78M Buy
+61,960
New +$1.87M 0.63% 19

Other funds holding PFE

Samjo Management's PFE Position: Q1 2026 in Review

Samjo Management reduced its Pfizer (PFE) stake by 0.83% in Q1 2026, selling an estimated $13.3K and leaving 59,645 shares worth $1.67M. The position accounts for 0.72% of the portfolio, ranked #34.

Samjo Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.34M in Q3 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Samjo Management held 59,645 shares of Pfizer worth $1.67M as of Q1 2026.
  • Samjo Management sold 500 Pfizer shares in Q1 2026, an estimated $13.3K.
  • Pfizer made up 0.72% of Samjo Management's portfolio in Q1 2026, its #34 holding.
  • Samjo Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Samjo Management's Pfizer position peaked at $2.34M in Q3 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Samjo Management's 13F filing for Q1 2026, filed 15 May 2026.